REQUEST A DEMO
Total
USD $0.00
Search more companies

Lupin Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lupin Ltd. Profile Updated: October 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lupin Ltd. is a global healthcare leader headquartered in Mumbai, India. Established in 1968 by Dr. Desh Bandhu Gupta, the company has expanded its presence across the U.S., LATAM, APAC, and EMEA regions, operating in over 100 countries. Lupin offers a diverse portfolio of over 1,000 products, including generics, complex generics, APIs, specialty, and biologics. Their focus areas include cardiovascular health, tuberculosis, diabetes, respiratory, gastrointestinal disorders, and women's health. Lupin is committed to making quality healthcare accessible to all and has a strong emphasis on social responsibility. They have a foundation called Lupin Human Welfare and Research Foundation (LHWRF) that positively impacts the lives of over 2.5 million people in India. The company aims to advance its infrastructure, embrace innovation, and expand its presence in high-growth markets to better serve patients worldwide.

Legal Address
Kalpataru Inspire, 3rd Floor, Off. Western Express Highway
Mumbai; Maharashtra; Postal Code: 400055

Contact Details: Purchase the Lupin Ltd. report to view the information.

Website: http://www.lupin.com

Basic Information
Total Employees:
Purchase the Lupin Ltd. report to view the information.
Outstanding Shares:
Purchase the Lupin Ltd. report to view the information.
Registered Capital:
Purchase the Lupin Ltd. report to view the information.
Financial Auditors:
Purchase the Lupin Ltd. report to view the information.
Incorporation Date:
1983
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Chief Executive
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
46.68%
Purchase this report to view the information.
21.5%
Purchase this report to view the information.
16.89%
Purchase this report to view the information.
8.21%
Purchase this report to view the information.
5.29%
Subsidiaries
Amel Touhoku
100%
Hormosan Pharma Gmbh.
100%
Kyowa Pharmaceutical Industry Co.,Ltd.
100%
Company Performance
Financial values in the chart are available after Lupin Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
14.55%
Total operating revenue
17.74%
Operating profit (EBIT)
77.99%
EBITDA
58.14%
Net Profit (Loss) for the Period
77.69%
Operating Profit Margin (ROS)
7.15%
Net Profit Margin
5.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?